Last update 23 Jan 2025

DOCK5 x GABAA receptor

Basic Info

Related Targets
DOCK5GABAA receptor

Related

1
Drugs associated with DOCK5 x GABAA receptor
Alprazolam
Target
DOCK5 x GABAA receptor
Mechanism
DOCK5 inhibitors [+1]
Active Org.
UCB Pharma SA [+7]
Originator Org.
Takeda Pharmaceutical Co., Ltd.Takeda Pharmaceutical Co., Ltd. [+1]
Active Indication
Catatonia [+7]
Inactive Indication
Drug abuse [+2]
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
US
First Approval Date16 Oct 1981
115
Clinical Trials associated with DOCK5 x GABAA receptor
CTRI/2024/12/077761
/ Not yet recruitingPhase 2/3IIT
A Randomized Controlled Clinical Trial to Evaluate the Efficacy of Brahmi (Bacopa monniera) Ghana Vati with Alprazolam as an Anxiolytic in Preanesthetic Management. - NIL
NCT06757140
/ Not yet recruitingPhase 1/2IIT
Opioid Drug Interactions: Safety, Abuse Potential and Pharmacokinetic Effects
100 Clinical Results associated with DOCK5 x GABAA receptor
Login to view more data
100 Translational Medicine associated with DOCK5 x GABAA receptor
Login to view more data
0 Patents (Medical) associated with DOCK5 x GABAA receptor
Login to view more data

Analysis

Perform a panoramic analysis of this field.
login
or
view full example data
Perform a panoramic analysis of this field.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free